Results 91 to 100 of about 18,378,232 (237)

Dual Portal Hypertension in Hepatic Tuberculosis: A Case Report

GE: Portuguese Journal of Gastroenterology
Background: Hepatic tuberculosis in itself is a rare condition, and that causing portal hypertension is even rarer. We present a unique clinical scenario of portal hypertension in a 64-year-old woman, with tuberculosis causing both sinusoidal ...
Amal Joseph, Prajob Geevarghese Prasad, Jeby Jacob, Harikumar Nair   +3 more
doaj   +1 more source

Portopulmonary hypertension practice patterns after liver transplantation

Liver Transplantation, EarlyView., 2022
Abstract Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...
Arun Jose, Elizabeth J. Kopras, Shimul A. Shah, Jean M. Elwing   +3 more
wiley   +1 more source

Simple blood tests to diagnose compensated advanced chronic liver disease and stratify risk of clinically significant portal hypertension. [PDF]

BACKGROUND AIMS Compensated advanced chronic liver disease (cACLD) identifies patients at risk for clinically significant portal hypertension (CSPH), and thus, for liver-related complications. Limited availability of liver stiffness measurements (LSM)
Aigner, Elmar, Fritz, Laurenz, Hofer, Benedikt Silvester, Quehenberger, Peter, Scheiner, Bernhard, Hartl, Lukas, Meyer, Elias Laurin, Szymanski, Robin, Reiberger, Thomas, Schwarz, Michael, Semmler, Georg, Mandorfer, Mattias, Trauner, Michael, Simbrunner, Benedikt, Berzigotti, Annalisa, Mendoza, Yuly Paulin, Jachs, Mathias, Schedlbauer, Anna, Maurer, Jurij, Stopfer, Katharina, Balcar, Lorenz, Neumayer, Daniela   +21 more
core   +1 more source

Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension [PDF]

, 2015
BACKGROUND The diagnostic performance of biochemical scores and artificial neural network models for portal hypertension and cirrhosis is not well established.
Robic, Marie Angele, Selves, Janick, Berzigotti, Annalisa, Agachi, Paul Serban, Vinel, Jean Pierre, Bureau, Christophe, Stefanescu, Horia, Procopet, Bogdan, Cristea, Vasile Mircea, Grigorescu, Mircea, Metivier, Sophie, Peron, Jean Marie   +11 more
core   +1 more source

Invasive and non Invasive methods to diagnose portal hypertension

, 2014
Assessing the presence of clinically significant portal hypertension and esophageal varices is clinically important in cirrhosis. The reference standard techniques to assess the presence of portal hypertension and varices are the measurement of the ...
R. de Franchis, A. Dell’Era
core   +1 more source

Landmark studies on clinically significant portal hypertension and decompensated cirrhosis

The presence of clinically significant portal hypertension and decompensated cirrhosis heralds a significant change in a patient’s trajectory, with an associated high morbidity and mortality.
Tsochatzis, Emmanouil, Reiberger, Thomas, Ferrentino, Filomena, Gananandan, Kohilan   +3 more
core   +1 more source

Idiopathic noncirrhotic portal hypertension: current perspectives

, 2016
Oliviero Riggio,1 Stefania Gioia,1 Ilaria Pentassuglio,1 Valeria Nicoletti,1 Michele Valente,2 Giulia d’Amati2 1Department of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension, 2Department of Radiological, Oncological,
Riggio O, Nicoletti V, Valente M, d’Amati G, Gioia S, Pentassuglio I   +5 more
core  

miRNA-122 could not predict portal hypertension.

, 2015
AUROC analysis demonstrated that we unfortunatelydid not succeeded to define a cut-off value to predict portal hypertension. (A) AUC of 0.639 (p = 0.214) for detecting an HVPG of 5mmHG.
Mattias Mandorfer (584776), Christian P. Strassburg (201852), Thomas Reiberger (143056), Jürgen K. Rockstroh (355014), Robert Schierwagen (605493), Evrim Anadol (605494), Jia Huang (42138), Hannah Eischeid (605491), Christian Jansen (605490), Philipp Schwabl (635845), Margarete Odenthal (180129), Markus Peck-Radosavljevic (143105), Jonel Trebicka (206006), Ute Warnecke-Eberz (688779), Carolynne Schwarze-Zander (688778)   +14 more
core   +1 more source

Primary Prophylaxis for High-Risk Varices in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus Delayed Hepatic Decompensation: A Retrospective, Propensity Score Matching Study

Journal of Hepatocellular Carcinoma
Yu-Jen Chen,1– 3 Ming-Chih Hou,1– 3 Tsung-Chieh Yang,1– 3 Pei-Chang Lee,1– 3 Hsiao-Sheng Lu,1– 3 Hui-Chun Huang,1– 3 Yi-Hsiang Huang,2,4,5 Jiing-Chyuan Luo1– 3 1Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General ...
Chen YJ, Hou MC, Yang TC, Lee PC, Lu HS, Huang HC, Huang YH, Luo JC   +7 more
doaj  

Navigating Tumor Thrombus: Transhepatic Portal Vein Stenting in Pancreatic Neuroendocrine Tumor

Journal of Clinical Interventional Radiology ISVIR
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are typically indolent but may occasionally present with advanced disease involving major vascular structures.
Saurabh Kumar, Apoorva Batra, Hershit Shrivastava   +2 more
doaj   +1 more source